Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Balance Sheets

v3.23.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 152,483 $ 178,266
Accounts receivable, net 27,616 28,208
Inventory 13,278 14,159
Other receivables - related party 636 138
Prepaid expenses and other current assets 8,368 9,661
Total current assets 202,381 230,432
Property, plant and equipment, net 12,194 13,020
Operating lease right-of-use asset, net 19,467 19,991
Restricted cash 2,438 2,688
Intangible asset, net 26,128 27,197
Other assets 943 973
Total assets 263,551 294,301
Current liabilities    
Accounts payable and accrued expenses 105,419 97,446
Deferred revenue 547 728
Income taxes payable 722 722
Common stock warrant liabilities 9,459 13,869
Operating lease liabilities, short-term 2,515 2,447
Partner company term loan, short-term, net 2,318  
Partner company convertible preferred shares, short-term, net 2,937 2,052
Partner company line of credit 3,000 2,948
Partner company installment payments - licenses, short-term, net 2,288 7,235
Other short-term liabilities 268 268
Total current liabilities 129,473 127,715
Notes payable, long-term, net 89,996 91,730
Operating lease liabilities, long-term 21,026 21,572
Partner company installment payments - licenses, long-term, net 1,450 1,412
Other long-term liabilities 1,800 1,847
Total liabilities 243,745 244,276
Commitments and contingencies (Note 14)
Stockholders' equity    
Cumulative redeemable perpetual preferred stock, $0.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 3,427,138 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively, liquidation value of $25.00 per share 3 3
Common stock, $0.001 par value, 200,000,000 shares authorized, 130,417,161 and 110,494,245 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 130 110
Additional paid-in-capital 693,433 675,841
Accumulated deficit (655,770) (634,233)
Total stockholders' equity attributed to the Company 37,796 41,721
Non-controlling interests (17,990) 8,304
Total stockholders' equity 19,806 50,025
Total liabilities and stockholders' equity $ 263,551 $ 294,301